Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andrew Abaasa"'
Autor:
Yunia Mayanja, Andrew Abaasa, Jim Todd, Stephen Nash, Patricia E. Fast, Pontiano Kaleebu, Matthew Price
Publikováno v:
AIDS and Behavior
Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) ne
Autor:
Gloria Omosa-Manyonyi, Andrew Abaasa, Hannah Nduta, Elizabeth Mueni Mutisya, Vincent Muturi-Kioi, Gaudensia Mutua, Joshua Kimani, Delvin Nyasani, Rhoda Kabuti, Matthew Price, AO Anzala, Krysia Lindan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 8, p e0238028 (2020)
BASE-Bielefeld Academic Search Engine
PLoS ONE, Vol 15, Iss 8, p e0238028 (2020)
BASE-Bielefeld Academic Search Engine
ObjectiveTo evaluate factors associated with willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.BackgroundWorking with 'key populations', those at elevated risk of H
Autor:
Jim Todd, Pontiano Kaleebu, Patricia E. Fast, Yunia Mayanja, Andrew Abaasa, Stephen Nash, Matthew Price
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
To prevent pregnancy in trials, reliable contraceptive use is key. We investigated reliable contraceptive use at baseline and six months in key-populations in Uganda, during two Simulated HIV Vaccine Efficacy trials (SiVETs). SiVETs were nested withi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa4fa1b424780f5ee0089e28f45411f
Autor:
Matthew Price, Anatoli Kamali, Ubaldo Bahemuka, Gershim Asiki, Eugene Ruzagira, Freddie Kibengo, Andrew Abaasa, Patricia E. Fast
Publikováno v:
Vaccine. 34:1778-1785
BackgroundClinical trial participants may differ from the source population due to the demands of trial participation and self-selection, inadvertent selection of a lower-risk group, or both. We investigated the HIV risk status of volunteers in a Sim
Autor:
Andrew Abaasa, Pontiano Kaleebu, Jim Todd, Patricia E. Fast, Anatoli Kamali, Matthew Price, Stephen Nash, Yunia Mayanja
Publikováno v:
SSRN Electronic Journal.
BACKGROUND: Fisherfolks (FF) and female sex workers (FSW) in Uganda could be suitable key populations for HIV vaccine efficacy trials because of the high HIV incidence and good retention in observational cohorts. However, the observed HIV incidence m
Autor:
Janet Seeley, Freddie Kibengo, Eugene Ruzagira, Pontiano Kaleebu, Gershim Asiki, Sinead Delany, Anatoli Kamali, Jerry Mulondo, Ubaldo Bahemuka, Andrew Abaasa, Linda-Gail Bekker
Publikováno v:
Vaccine. 31(44)
HIV vaccine efficacy trials conducted in suitable populations are anticipated in sub-Saharan Africa. We assessed the willingness to participate in future vaccine trials among individuals from fishing communities along Lake Victoria, Uganda.From July
Autor:
Anatoli Kamali, Andrew J. Nunn, Richard J. Hayes, Symon Wandiembe, Jonathan Levin, Sheena McCormack, Angela M. Crook, Andrew Abaasa, Mitzy Gafos, Zacchaeus Anywaine, Ananta Nanoo
Publikováno v:
Trials, Vol 14, Iss 1, p 33 (2013)
Trials
Europe PubMed Central
Trials
Europe PubMed Central
Background A safe and effective vaginal microbicide could substantially reduce HIV acquisition for women. Consistent gel use is, however, of great importance to ensure continued protection against HIV infection, even with a safe and effective microbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::facfd560bb89baaf71e406c8f9581b0d